|
|
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008
Wajeh Qunibi, MD and Charles R. Nolan, MD
(MER CME Conference, January, 2008.)
|
| |
|
Aldosterone: New Insights in Kidney Health and Disease
David A. Calhoun, MD and Mark E. Rosenberg, MD
(ASN Renal Week Clinical Nephrology Conference. November, 2007.)
|
| |
|
|
RPA 2008 Annual Meeting. General Sessions 1 and 2
RPA: Year in Review
Alan Kliger, MD
RPA's Advocacy Agenda
Robert Blaser, MD
Brian Ling Lecture: Pay for Performance is Here! Lessons of success from Medicare Physician Payment Demonstration Project
Karl Ulrich, MD
ESA Payment Update: Where Knowledge Meets Politics
Alan Nissenson, MD
Value and Courage in Politics: Nephrology Reaches Farther
Rebecca Schmidt, MD
Value and Courage in Politics: Nephrology Reaches Farther
Larry Lehrner, MD
|
| |
|
|
Advances in CKD. Part Three of Five.
(Renal Research Institute 10th International Conference. January, 2008.)
Angiotensin II, interstitial inflammation and the pathogenesis of salt sensitive hypertension
Martha Franco, MD, PhD
How common is malnutrition in ESRD? An approach to diagnosis and management
Martin Kuhlmann, MD
Blind Pugh sends a black spot: The current hemoglobin controversy
Paul E. Stevens, MB, FRCP
KEYNOTE ADDRESS: The metabolic syndrome and kidney disease
Eberhard Ritz, MD
Transplant and CKD patients at the same stage of renal insufficiency: how are they the same or different?
Warren Kupin, MD, FACP
|
| |
AUDIOFILE SELECTION (now also in MP3 format) -
Renal Week 2007 and PGE Talks
AUDIOFILE LIST
INTERVENTIONAL NEPHROLOGY: WHAT NEPHROLOGISTS SHOULD KNOW (Part 2 of 2)
Complications of Tunneled HD Catheters
Antoine L. Samaha, MD
Management of Catheter Infection
Bharat S. Sachdeva, MD
Peritoneal Dialysis Catheters: Peritoneoscopic Method
Stephen R. Ash, MD
Peritoneal Dialysis Catheters: Fluoroscopic Method
Ivan D. Maya, MD
Percutaneous Balloon Angioplasty Procedure
Alexander S. Yevzlin, MD
Management of Central Venous Stenosis
Florin N. Gadalean, MD
Hand Ischemia
Steven Wu, MD
Preservation of Veins?
Edgar V. Lerma, MD, FASN
Evaluation Stents: Do They Work?
Kenneth D. Abreo, MD
Vascular Access Center: What Does It Mean for You and What Does It Do for the Patient?
Donald Schon, MD
|
Nephros® - - "Taking
Hemodiafiltration to a Higher Level"
Nephros makes a unique mid-dilution hemodiafiltration (HDF) filter, the
OL-pur-MD 190, where
blood is first routed through a peripheral region of the hollow-fiber
bundle.
Blood is then diluted with replacement fluid in the back header, and then
flow is reversed
through the core of the fiber bundle. This allows very high replacement
fluid flow
rates and β-2 microglobulin clearances in the range of 150 - 200
mL/min, twice as
high as with standard, post-dilution HDF. The OL-pur-MD 190 can be used
with standard on-line
HDF machines. The filter has CE approval in Europe; not approved yet in
the United States.
For more information about the OL-pur-MD 190 filter and Nephros, please
visit the
new Nephros® VIRTUAL EXHIBIT
BOOTH . .
|
|
 |
|
|
 |
ADVERTISEMENT |
|
